Milagros Testillano Selected Research

Milagros Testillano Research Topics

6	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 01/2012
4	Fibrosis (Cirrhosis) 11/2022 - 01/2015
3	Hepatitis C 11/2022 - 12/2017
3	Infections 10/2018 - 10/2017
2	Thrombosis (Thrombus) 11/2022 - 11/2022
2	Chronic Hepatitis C 08/2015 - 08/2006
2	Chronic Hepatitis B 01/2015 - 05/2012
1	Disease Progression 11/2022
1	Neoplasms (Cancer) 11/2022
1	Sepsis (Septicemia) 11/2022
1	Brain Death (Brain Dead) 12/2021
1	Ascites 11/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2016
1	Hypertension (High Blood Pressure) 01/2015
1	Obesity 01/2015
1	Diarrhea 01/2012
1	Mucositis 01/2012
1	Hyperglycemia 01/2012
1	Viremia 08/2006
1	Encephalitis (Encephalitis, Rasmussen) 01/2002

3	Antiviral Agents (Antivirals)IBA 10/2018 - 10/2017
3	Sorafenib (BAY 43-9006)FDA Link 11/2017 - 01/2012
2	Tacrolimus (Prograf)FDA LinkGeneric 03/2021 - 10/2016
2	InterferonsIBA 10/2018 - 08/2015
2	Ribavirin (Virazole)FDA LinkGeneric 08/2015 - 08/2006
2	entecavir FDA Link 01/2015 - 05/2012
1	NivolumabIBA 11/2022
1	SirtuinsIBA 11/2022
1	Immune Checkpoint InhibitorsIBA 11/2022
1	BilirubinIBA 11/2017
1	daclatasvirIBA 10/2017
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 08/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 08/2015
1	telaprevirIBA 08/2015
1	HCV NS3-4A Protease InhibitorsIBA 08/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2015
1	TOR Serine-Threonine KinasesIBA 01/2012
1	MTOR InhibitorsIBA 01/2012
1	RNA (Ribonucleic Acid)IBA 08/2006

8	Liver Transplantation 11/2022 - 01/2002
4	Therapeutics 12/2017 - 08/2006
1	Radiotherapy 11/2022
1	Stents 11/2022
1	Thrombectomy 11/2022
1	Immunotherapy 11/2022
1	Surgical Splenorenal Shunt (Splenorenal Shunt) 11/2022
1	Splenectomy 11/2022